2-(n,n-dimethylamino)-6,7-dihydroxytetralin has been researched along with quinoxalines in 1 studies
| Studies (2-(n,n-dimethylamino)-6,7-dihydroxytetralin) | Trials (2-(n,n-dimethylamino)-6,7-dihydroxytetralin) | Recent Studies (post-2010) (2-(n,n-dimethylamino)-6,7-dihydroxytetralin) | Studies (quinoxalines) | Trials (quinoxalines) | Recent Studies (post-2010) (quinoxalines) |
|---|---|---|---|---|---|
| 46 | 0 | 0 | 9,887 | 625 | 3,095 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rand, MJ; Xiao, XH | 1 |
1 other study(ies) available for 2-(n,n-dimethylamino)-6,7-dihydroxytetralin and quinoxalines
| Article | Year |
|---|---|
Alpha 2-adrenoceptor agonists enhance vasoconstrictor responses to alpha 1-adrenoceptor agonists in the rat tail artery by increasing the influx of Ca2+.
Topics: Adrenergic alpha-Agonists; Animals; Arteries; Brimonidine Tartrate; Calcium; Diltiazem; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Norepinephrine; Perfusion; Phenylephrine; Quinoxalines; Rats; Rats, Inbred Strains; Regional Blood Flow; Tail; Tetrahydronaphthalenes; Vasoconstriction | 1989 |